Modest effect of statins on fasting glucose in a longitudinal electronic health record based cohort.
Modest effect of statins on fasting glucose in a longitudinal electronic health record based cohort.
复制标题
他汀类药物对基于纵向电子健康记录的队列中禁食葡萄糖的适度作用。
DOI:
10.1186/s12933-022-01566-w
复制
发表时间:
2022-07-14
影响因子:
9.3
通讯作者:
中科院分区:
文献类型:
--
作者:
Prior studies of the glycemic effect of statins have been inconsistent. Also, most studies have only considered a short duration of statin use; the effect of long-term statin use on fasting glucose (FG) has not been well examined. The aim of this work is to investigate the effect of long-term statin exposure on FG levels. Using electronic health record (EHR) data from a large and diverse longitudinal cohort, we defined long-term statin exposure in two ways: the cumulative years of statin use (cumulative supply) and the years’ supply-weighted sum of doses (cumulative dose). Simvastatin, lovastatin, atorvastatin and pravastatin were included in the analysis. The relationship between statin exposure and FG was examined using linear regression with mixed effects modeling, comparing statin users before and after initiating statins and statin never-users. We examined 593,130 FG measurements from 87,151 individuals over a median follow up of 20 years. Of these, 42,678 were never-users and 44,473 were statin users with a total of 730,031 statin prescriptions. FG was positively associated with cumulative supply of statin but not comulative dose when both measures were in the same model. While statistically significant, the annual increase in FG attributable to statin exposure was modest at only 0.14 mg/dl, with only slight and non-significant differences among statin types. Elevation in FG level is associated with statin exposure, but the effect is modest. The results suggest that the risk of a clinically significant increase in FG attributable to long-term statin use is small for most individuals. The online version contains supplementary material available at 10.1186/s12933-022-01566-w.
登录
查看更多内容
影响因子:
168.9
作者:
Ridker, Paul M.;Pradhan, Aruna;MacFadyen, Jean G.;Libby, Peter;Glynn, Robert J.
通讯作者:
Glynn, Robert J.
DOI:
10.1136/bmj.f2610
发表时间:
2013-05-23
期刊:
BMJ (Clinical research ed.)
影响因子:
--
作者:
Carter AA;Gomes T;Camacho X;Juurlink DN;Shah BR;Mamdani MM
通讯作者:
Mamdani MM
影响因子:
3.2
作者:
Ma, Tsochiang;Tien, Liyun;Jong, Gwo-Ping
通讯作者:
Jong, Gwo-Ping
影响因子:
2.6
作者:
Sukhija, Rishi;Prayaga, Sastry;Mehta, Jawahar L.
通讯作者:
Mehta, Jawahar L.
影响因子:
168.9
作者:
Sattar, Naveed;Preiss, David;Ford, Ian
通讯作者:
Ford, Ian